click below
click below
Normal Size Small Size show me how
Diabetes Drugs
| Brand | Generic | Class | Indication | |
|---|---|---|---|---|
| Novolog | Insulin Aspart | Rapid-Acting (Prandial) | Required for Type 1 DM May be used in Type 2 DM | |
| Apidra | Insulin Glulisine | Rapid-Acting (Prandial) | Required for Type 1 DM May be used in Type 2 DM | |
| Humalog | Insulin Lispro | Rapid-Acting (Prandial) | Required for Type 1 DM May be used in Type 2 DM | |
| Afrezza | Inhaled Insulin | Rapid-Acting (Prandial) | Required for Type 1 DM May be used in Type 2 DM | |
| Humulin R, Novolin R | Regular Insulin | Short-Acting (Prandial) | Required for Type 1 DM May be used in Type 2 DM | |
| Humulin N, Novolin N | Neutral Protamine Hagedorn (NPH) insulin | Intermediate-Acting (Basal) | Required for Type 1 DM May be used in Type 2 DM | |
| Lantus | Insulin Glargine | Long-Acting (Basal) | Required for Type 1 DM May be used in Type 2 DM | |
| Tresiba | Insulin Degludec | Long-Acting (Basal) | Required for Type 1 DM May be used in Type 2 DM | |
| Tzield | Teplizumab | Anti-CD3 Antibody | Type 1 DM (Delays onset of Stage 3) | |
| IR (BID): Byetta ER (weekly): Bydureon | Exenatide | Incretin Mimetics (GLP-1 Agonist) | Type 2 DM | |
| Trulicity | Dulaglutide | Incretin Mimetics (GLP-1 Agonist) | Type 2 DM; CVD & CKD benefit | |
| PO: Rybelsus | Semaglutide | Incretin Mimetics (GLP-1 Agonist) | Type 2 DM; HF, CKD, CVD benefit | |
| SQ: Ozempic, Wegovy | Semaglutide | Incretin Mimetics (GLP-1 Agonist) | Type 2 DM, Weight loss, HF, CKD, CVD benefit | |
| Victoza, Saxenda* | Liraglutide | Incretin Mimetics (GLP-1 Agonist) | Type 2 DM, Weight loss*, CKD, CVD benefit | |
| Mounjaro, Zepbound | Tirzepatide | Incretin Mimetics (GLP-1 & GIP Agonist) | Type 2 DM, Weight loss*, CKD, CVD benefit | |
| Amaryl | Glimepiride | Sulfonylurea (Insulin Secretagogues) | Type 2 DM | |
| Glucotrol, Glucotrol XL | Glipizide | Sulfonylurea (Insulin Secretagogues) | Type 2 DM | |
| DiaBeta | Glyburide | Sulfonylurea (Insulin Secretagogues) | Type 2 DM | |
| Fortamet, Glumetza, Glucophage | Metformin | Biguanide | Type 2 DM, PCOS | |
| Actos | Pioglitazone | Thiazolidinedione | Adjunct therapy for Type 2 DM (requires insulin) | |
| Januvia | Sitagliptin | DPP-IV Inhibitors | Type 2 DM | |
| Tradjenta | Linagliptin | DPP-IV Inhibitors | Type 2 DM | |
| Onglyza | *Saxagliptin | DPP-IV Inhibitors | Type 2 DM | |
| Nesina | *Alogliptin | DPP-IV Inhibitors | Type 2 DM | |
| Invokana | Canagliflozin | Sodium-glucose Cotransporter 2 inhibitor | Type 2 DM, HF, CKD, CVD | |
| Jardiance | Empagliflozin | Sodium-glucose Cotransporter 2 inhibitor | Type 2 DM, HF, CKD, CVD | |
| Farxiga | Dapagliflozin | Sodium-glucose Cotransporter 2 inhibitor | Type 2 DM, HF, CKD | |
| Steglatro | Ertugliflozin | Sodium-glucose Cotransporter 2 inhibitor | Type 2 DM, HF | |
| Brenzavvy | Bexagliflozin | Sodium-glucose Cotransporter 2 inhibitor | Type 2 DM, HF | |
| Inpefa | Sotagliflozin | Dual Sodium-glucose Cotransporter inhibitor | Type 2 DM, HF |